Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Total Liabilities (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Total Liabilities readings, the most recent being $103.2 million for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 0.91% to $103.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $103.2 million, a 0.91% decrease, with the full-year FY2025 number at $103.2 million, down 0.91% from a year prior.
  • Total Liabilities hit $103.2 million in Q4 2025 for Treace Medical Concepts, down from $107.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $116.3 million in Q1 2024 to a low of $38.1 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $100.1 million (2023), compared with a mean of $88.8 million.
  • Biggest five-year swings in Total Liabilities: surged 49956.96% in 2021 and later dropped 13.61% in 2025.
  • Treace Medical Concepts' Total Liabilities stood at $47.7 million in 2021, then skyrocketed by 106.28% to $98.5 million in 2022, then grew by 15.71% to $114.0 million in 2023, then dropped by 8.57% to $104.2 million in 2024, then decreased by 0.91% to $103.2 million in 2025.
  • The last three reported values for Total Liabilities were $103.2 million (Q4 2025), $107.4 million (Q3 2025), and $108.8 million (Q2 2025) per Business Quant data.